Mochida Pharmaceuticals Reports Increase in Revenue, High Expectations for Lexapro in 2012
This article was originally published in PharmAsia News
Executive Summary
Mochida Pharmaceuticals announced Lexapro generated ¥600 million in six months, and is expected to generate about ¥4 billion in 2012.